We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cepheid Expands Distribution into Latin America

By HospiMedica staff writers
Posted on 22 Apr 2004
Following the signing of multi-year distribution agreements, Cepheid (Sunnyvale, CA, USA; www.cepheid.com) has announced the company will market its SmartCycler portable laboratory system along with accessories and disposables in Mexico and Brazil.

The SmartCycler is a thermal cycler with real-time optical detection that can be used to quickly and accurately detect infectious disease agents, human genes, and industrial or environmental contamination. More...
Cepheid signed marketing agreements with BioAgency Co. Ltd. (Sao Paulo, Brazil) and Industrias Bioselec S.A. de C.V. (Mexico City, Mexico). Both companies will provide marketing, sales, and service support for the SmartCycler product line.

"Both BioAgency and Biocelec are companies that have a well-earned reputation as quality business units that maintain high standards of customer service,” noted Ira Marks, vice president, worldwide sales & marketing, Cepheid. "These relationships will help to strongly position Cepheid's products in selected Latin American territories and will enhance Bioagency's and Bioselec's roles in the developing life science and genomic testing markets.




Related Links:
Cepheid

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Urinalysis Solution
UN-9000
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.